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Abstract
The chirality, or ‘handedness’, of a biologically active molecule can alter its physiological 
properties. For this reason, it is routine procedure in the drug discovery and development process 
to prepare and fully characterize all possible stereoisomers of a drug candidate for biological 
evaluation1,2. Despite many recent advances in asymmetric synthesis, the development of general 
and practical strategies to obtain all possible stereoisomers of an organic compound bearing 
multiple contiguous stereocenters remains a significant challenge3. In this manuscript, we report a 
stereodivergent copper-based approach for the expeditious construction of amino alcohols with 
high levels of chemo-, regio-, diastereo- and enantioselectivity. Specifically, these amino alcohol 
products were synthesized using the sequential copper hydride-catalyzed hydrosilylation and 
hydroamination of readily available enals and enones. This strategy provides a route to all possible 
stereoisomers of the amino alcohol products, which contain up to three contiguous stereocenters. 
Catalyst control and stereospecificity were simultaneously leveraged to attain exceptional control 
of the product stereochemistry. Beyond the utility of this protocol, the strategy demonstrated here 
should inspire the development of methods providing complete sets of stereoisomers for other 
valuable synthetic targets.
Different stereoisomers of drugs can have distinct therapeutic properties or adverse effects 
due to the chiral environments of enzymes and receptors in biological systems. The most 
well known example is thalidomide, the R-enantiomer of which was an effective sedative, 
while the S-enantiomer caused severe teratogenic side effects and resulted in tragic birth 
defects during the 1950s. Stereoisomers of drugs can also have contrasting indications as in 
the case of quinine and quinidine or even opposing biological activities (Fig. 1a and 1b). For 
these reasons, regulatory agencies require the evaluation of the bioactivity of all 
stereoisomers of pharmaceutical candidates during the drug discovery and development 
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process1,2. Furthermore, manufacturers must develop assays to determine stereochemical 
purity to ensure drug safety. Consequently, all stereoisomers of a molecule must be prepared 
for use in biological testing or as standard samples. Thus, the construction of complete 
stereoisomeric sets represents a practically important synthetic problem as well as a 
fundamentally significant research topic1,2.
In the past few decades, asymmetric synthesis has witnessed tremendous progress, providing 
numerous chiral bioactive compounds with high levels of selectivity3. Although asymmetric 
catalysis has allowed enantiomers of a chiral molecule to be obtained with equal ease, 
relatively few methods are capable of providing a unified route leading to all possible 
stereoisomers of products containing multiple contiguous stereocenters. Thus, full control of 
absolute and relative stereochemical configuration remains an unmet synthetic challenge3. 
Aside from classical techniques in asymmetric catalysis, such as the use of additives4,5, 
modification of catalyst structure6–10, and variation of substrate protecting group11,12, multi-
catalytic approaches13–16 have been advanced to access the full complement of 
stereoisomers for certain classes of compounds. MacMillan has previously described the 
novel concept of cycle-specific amino-catalysis in which two chiral catalysts sequentially 
perform an iminium/enamine catalysis cascade to selectively functionalize enals13,14. 
Carreira recently demonstrated an elegant dual catalyst system to independently control the 
two stereocenters for the α-allylation of branched aldehydes15,16. Despite these important 
developments, a rapid and predictable approach to access complete stereoisomeric sets of 
important products bearing multiple stereocenters (e.g. three contiguous stereocenters) from 
readily available precursors based on a single catalyst system would be highly desirable but 
remains underdeveloped.
Optically pure amino alcohols are important structural elements frequently found in 
pharmaceutical agents and bioactive natural products (Fig. 1b)17. Moreover, these 
compounds also serve as important building blocks for catalysts and auxiliaries in 
asymmetric synthesis. We speculated that our recently disclosed catalytic systems18–23 for 
enantioselective hydroamination24,25 based on copper hydride (CuH) intermediates26 and 
electrophilic aminating reagents27 could be applied to the synthesis of this class of 
compounds. We hypothesized that enals and enones, which are readily available as 
geometrically pure isomers, could serve as ideal precursors to amino alcohols. In particular, 
we anticipated that a CuH-based catalyst could reduce enals and enones chemoselectively to 
the corresponding allylic alcohols, which would undergo regio- and stereoselective 
hydroamination to afford amino alcohol products bearing multiple contiguous stereocenters 
in one synthetic operation (Fig. 1c). As a consequence of the synfacial nature of the 
hydroamination process, we reasoned that this two-step sequence would be stereospecific 
with respect to olefin geometry. Thus, effective catalyst-control would allow the generation 
of all diastereomeric possibilities through the appropriate choice of substrate geometry (E or 
Z) and ligand enantiomer (R or S). Although the asymmetric hydrosilylation of ketones 
using a copper catalyst is a well-known process28, we were aware that 1,2-reduction of α, β-
unsaturated carbonyl compounds by CuH is less favorable than 1,4-reduction due to the 
inherent preference of Cu to coordinate to the olefin via soft−soft interactions26. Pioneering 
work by Stryker29 and Lipshutz30 suggested that control of the regioselectivity in the CuH 
reduction of Michael acceptors was sensitive to subtle variation in steric and electronic 
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properties of the ligand and the substituents of substrates. On the other hand, the control of 
regio- and stereoselectivity of hydroamination step is also non-trivial25, due to the steric and 
electronic bias of the allylic silyl ether intermediates and potential matched/mismatched 
effects between substrates and chiral catalysts. Here, we report a copper-based catalyst 
system for the execution of this strategy that provides access to all possible amino alcohol 
stereoisomers in high chemo-, regio-, diastereo- and enantioselectivity starting from readily 
available enals and enones.
In initial efforts to implement this proposed hydrosilylation/hydroamination sequence, we 
first treated (E)-2-methyl-cinnamaldehyde (1a) with an excess of dimethoxymethylsilane in 
the presence of 5 mol % of copper acetate and (S)-DTBM-SEGPHOS (L1) at room 
temperature for 15 minutes. Neither the conventional 1,4-reduction product nor the over-
reduced saturated alcohol was observed and the desired 1,2-adduct was obtained in nearly 
quantitative yield. Further treatment of the reaction mixture with aminating reagent 2a at 
55 °C effectively provided the amino alcohol 3a in 95% yield and with complete diastereo- 
and enantioselectivity (>20/1 d.r., >99% e.e.). A thorough evaluation of the electrophilic 
amine source indicated that 2a was the optimal aminating reagent. We attributed the high 
efficiency of 2a to the electron-rich para-diethylaminobenzoyl group. This group resulted in 
slower reductive decomposition of 2a and presumably faster regeneration of the CuH 
catalyst through σ-bond metathesis between the corresponding copper benzoate species and 
hydrosilane species22,23. L1 was the best ligand among the phosphines screened both in 
terms of reactivity and selectivity (See Supplementary Information for details).
With these optimized reaction conditions, we investigated the substrate scope of this one-pot 
transformation. We found that an array of β-aryl substituted (E)-enals could be efficiently 
transformed to the corresponding chiral amino alcohols in a highly regio-, diastereo- and 
enantioselective manner (Fig. 2, 3a–3n). A diverse range of hydroxylamine esters and enals 
with a variety of functional groups were suitable coupling partners for this sequential 
transformation, including phenols (3g, 3h), an aryl chloride (3k), an ester (3h), an acetal 
(3d), a trifluoromethoxyl (3e), cis-olefins (3f, 3l) and a trimethylsilanyl group (from the 
reaction of a vinyl silane) (3l). In addition to acyclic substrates, both a cyclic enal and cyclic 
aminating reagents were compatible, providing the products with high levels of stereocontrol 
(3d, 3i, 3k). Furthermore, substrates bearing a broad range of pharmaceutically important 
heteroaromatic components–including an indole (3g), a thiophene (3f), a pyridine (3h), a 
pyrrole (3j), a pyrimidylpiperidine (3i), and a chromene (3k)–could be readily converted to 
the desired products in excellent enantioselectivity. Additionally, an enal substrate bearing a 
ketone functional group smoothly underwent double hydrosilylation and hydroamination 
sequence under these conditions, furnishing amino diol (3m) bearing three stereocenters as a 
single stereoisomer. Lastly, a reaction conducted on a 5 mmol scale with decreased catalyst 
loading (1 mol%) efficiently provided the desired product (3a) in undiminished yield and 
stereoselectivity, demonstrating the robustness and practicality of this process.
As previously described, we were particularly interested in applying this approach to 
selectively access all of the possible stereoisomers, with high diasterero- and enantiocontrol 
for a given substrate. We felt that the use of the (Z)-enal substrate would lead to the 
formation of the complementary pair of diastereomers as that realized from the (E)-enal 
Shi et al. Page 3





















substrate. Accordingly, (Z)-2-amyl-cinnamaldehyde (1b) was subjected to the current 
reaction conditions, and produced the desired diastereomeric syn-amino alcohol in high 
chemical yield with complete diastereo- and enantioselectivity. Thus, by using the proper 
combinations of the enantiomer of ligand for the CuH catalyst and the olefin geometry of the 
enal substrate, all four stereoisomers of the corresponding amino alcohol could be readily 
prepared with full control of absolute and relative stereochemistry (Fig. 3a).
We also found that amino alcohols bearing three stereogenic centers could be generated in 
excellent catalyst-controlled diastereoselectivity when chiral hydroxylamine esters were 
used. The existing α-stereocenter on chiral aminating reagents did not interfere with the 
stereoselectivity when applied to the current catalyst system. Thus, all eight stereoisomers of 
the amino alcohol 3n were easily constructed in good yield and excellent diastereoselectivity 
in one step by selecting the appropriate enantiomer of the chiral aminating reagent and 
geometric isomer of the enal substrate as starting materials and employing either enantiomer 
of the chiral catalyst (Fig. 3b).
We then sought to examine the possibility of using enones as substrates for the rapid 
synthesis of chiral amino alcohols with three contiguous stereocenters. Based on Lipshutz’s 
exceptional work on the asymmetric CuH-catalyzed 1,2-reduction of enones30, we found 
that readily accessible enone 4a could be effectively converted to the corresponding chiral 
allylic alcohol in quantitative yield and 92 % e.e. at −60 °C in the presence of 5 mol % of 
Cu(OAc)2-L1 complex. Upon addition of the aminating reagent to the reaction mixture 
while heated at 55 °C, 5a was furnished in 76% chemical yield with complete diastereo- and 
enantioselectivity (>20/1 d.r., >99% e.e.). Under these reaction conditions, a variety of 
enones were transformed successfully to the respective amino alcohol products (Fig. 4, 5a–
5f) with excellent absolute and relative stereoselectivity (>20/1 d.r., >99% e.e.). In addition, 
a cyclic enone was converted into indanyl amino alcohol 5g in high diastereoselectivity 
(10/1 d.r.) and outstanding enantioselectivity (>99% e.e.) for both diastereomers. Lastly, we 
found that α-substitution on the enone was not crucial for selective 1,2-reduction. For 
instance, less substituted product 5h could be obtained in high enantioselectivity and 
synthetically useful diastereomeric ratio from benzylidenacetone.
Subsequently, we wondered whether these conditions could be adapted to the 
stereodivergent construction of all eight stereoisomers of 5a. Above (Fig. 4), we prepared 
(S,S,R)-5a from (E)-4a in a one-pot sequence by employing (S)-L1 as the ligand. To prepare 
(S,R,S)-5a, we developed a modified protocol involving a ligand switch in which (E)-4a was 
first hydrosilylated using (S)-L1 as the ligand, and the resulting chiral allylic alcohol was 
isolated and subjected to hydroamination conditions using copper catalyst based on (R)-L1. 
Use of enantiomeric ligands for the one-pot and ligand switch protocols yielded (R,R,S)- 
and (R,S,R)-5a, respectively, allowing four of the possible stereoisomers of 5a to be 
prepared from (E)-4a. We sought to prepare the four remaining stereoisomers of 5a from 
(Z)-4a by employing a similar strategy. The same ligand-switch protocol applied to (Z)-4a 
furnished (R,S,S)-5a and (S,R,R)-5a. Initial attempts to prepare (S,S,S)-5a and (R,R,R)-5a 
were unsuccessful, presumably due to the unfavorable steric interactions between the 
intermediate chiral (Z)-allylic alcohol and L1-based catalyst. Accordingly, a less bulky 
ligand, DM-SEGPHOS (L2), was selected for the hydroamination step to obtain these 
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products. Ultimately, all eight stereoisomers of 5a were prepared expediently in one to two 
steps in useful isolated yields (33 to 76%), with complete enantioselectivity (>99% e.e.) and 
good to excellent diastereoselectivity (7:1 - >20:1 produced in the reaction mixture prior to 
purification) (Fig. 5a). Upon isolation and chromatographic, all isomers were obtained in 
>20/1 d.r., as confirmed by the HPLC traces displayed in Fig. 5b. These results indicate that 
the enantioselective hydroamination steps proceeded through excellent catalyst-control in all 
eight cases.
In conclusion, we have developed a unified and stereodivergent strategy for the rapid and 
predictable construction of amino alcohols amenable to the synthesis of all possible 
stereoisomers of a given product. This practical protocol assembles two or three contiguous 
stereocenters utilizing enal and enone substrates in a highly selective copper catalyzed 
hydrosilylation/hydroamination sequence. The application of a stereospecific process to 
readily obtained pure geometric isomers of alkenes and highly effective catalyst control were 
critical aspects of our approach and may prove to be generally applicable to the development 
of other enantio- and diastereodivergent hydrofunctionalization reactions.
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Figure 1. Bioactive stereoisomers and strategies for construction of all stereoisomers of amino 
alcohols
a Different enantiomers give distinct activities in biological systems. b. Stereoisomeric 
amino alcohols (esters) and their biological activities. c. Top, potential side reactions; 
Bottom (this work), forming all stereoisomers of amino alcohols via selective 
hydrosilylation/hydroamination reactions.
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Figure 2. Asymmetric hydrosilylation/hydroamination of enals
Top row, reaction studied; Bottom rows, substrate scope. Isolated yields are reported 
(average of two runs on 0.5 mmol scale). Diastereomeric ratios (d.r.) were determined by 
GC and NMR analysis. Enantiomeric excesses (e.e.) were determined by HPLC analysis 
using chiral stationary phases. *Reaction was conducted in 5 mmol scale. See 
Supplementary Information for details. Bn, benzyl; PMB, p-methoxylbenzyl; RT, room 
temperature.
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Figure 3. All stereoisomers of amino alcohols from enals
a Reaction using (S)-L1 and (E)-2-amyl-cinnamaldehyde (1b) under the standard 
conditions; *using (R)-L1 instead of (S)-L1; †using (Z)-1b instead of (E)-1b. b Reaction 
using (S)-L1, (E)-2-methyl-cinnamaldehyde (1a) and 2j under the standard 
conditions; *using (R)-L1 instead of (S)-L1; ‡using (Z)-1a instead of (E)-1a; #using ent-2j 
instead of 2j.
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Figure 4. Asymmetric hydrosilylation/hydroamination of enones
Top row, reaction studied; Bottom rows, substrate scope. Isolated yields are reported 
(average of two runs on 1.0 mmol scale). Diastereomeric ratios (d.r.) were determined by 
GC and NMR analysis. Enantiomeric excesses (e.e.) were determined by HPLC analysis. * 
The absolute and relative stereochemistry of 5a was determined to be (S,S,R) by single 
crystal X-ray diffraction. See Supplementary Information for details.
Shi et al. Page 10





















Figure 5. All eight stereoisomers of amino alcohols from enones
a Access to all stereoisomers via reaction using (E)- or (Z)-4a with catalyst permutation in 
each step. Isolated yields are reported. Diastereomeric ratios (d.r.) were determined by NMR 
analysis using a crude reaction mixture. b HPLC traces of all stereoisomeric amino alcohol 
samples. See Supplementary Information for details.
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